Beetham Thomas W. bought VRDN
March 2, 2026 · Form 4 insider transaction
Beetham Thomas W. bought 35,300 shares of Viridian Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
35,300
Price
$0.00
Total value
N/A
InsiderBeetham Thomas W.
RoleOfficer
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateMarch 2, 2026
Filing dateMarch 4, 2026
Shares owned after35,300
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of the Issuer.; The RSUs vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 2, 2026, subject to the Reporting Person's continued service to Issuer through each vesting date.